Name: PHARMING GROUP Initial Public offering, New Issue Special Session
Start: Thu 27/05/2010 - 12:00
End: Thu 27/05/2010 - 12:00
Location: Euronext

Identification

Symbol

PHARM

ISIN code

NL0000377018

Exchange / Market

Euronext

Trading location

Amsterdam

Products family

Stocks

Market organization

Euronext-LocalSecurities

ICB

Biotechnology

Activity description

Pharming Group specializes in the development of innovative products for the treatment of genetic disorders, specialty products for surgical indications, and nutritional products. The group's technologies include innovative platforms for the production of protein therapeutics, technology and processes for the purification and formulation of these products, as well as technology in the field of DNA repair (DNAge). Net sales break down by type of revenues into grants (69.4%) and licence fees (30.6%).

Website address

www.pharming.com

Issuer website

www.pharming.com

Operation

IPO date

Thu 27/05/2010

IPO type

Initial Public offering

New Issue Special Session

Catégorie

New Issue Special Session

Operation procedure

OFFER SHARES